Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Microbot Medical Announces Total Gross Proceeds of Approximately $11.8 Million from Offering

Jan 07, 2025•over 1 year ago

Contract Type

partnership

BraintreeBiotechnologyHealthcareHealth Care

Description

Microbot Medical Inc. has closed a registered direct offering and concurrent private placement, raising approximately $11.8 million of gross proceeds. H.C. Wainwright & Co

Company Information

Company

Microbot Medical

Location

288 GROVE STREET

Braintree, Massachusetts, United States

About

Microbot Medical’s vision is to improve the quality of life of millions of patients globally by advancing robotic technologies to perform surgical procedures within the human body, and offer physicians and their patients less invasive and more precise solutions. The company’s innovations tap into one of the fastest-growing spaces in the medical field, the minimal invasive space. Microbot Medical develops robotic medical devices that provide doctors and surgeons with new technological capabilities to improve a patient’s health, comfort and quality of life. Microbot’s current technological platforms, LIBERTY® Robotic System, one&done™ ViRob™ and TipCAT™, are comprised of highly advanced technologies from which the Company is currently developing.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Microbot Medical's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months